Valiant Laboratories Ltd. (IN:VALIANTLAB)
:VALIANTLAB
Want to see IN:VALIANTLAB full AI Analyst Report?
Total Valuation
Valiant Laboratories Ltd. has a market cap or net worth of ₹4.04B. The enterprise value is ₹4.52B.
Market Cap₹4.04B
Enterprise Value₹4.52B
Share Statistics
Valiant Laboratories Ltd. has 54,312,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding54,312,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Valiant Laboratories Ltd.’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -0.41%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-0.41%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee30.84M
Profits Per Employee-424.40K
Employee Count77
Asset Turnover0.51
Inventory Turnover4.63
Valuation Ratios
The current PE Ratio of Valiant Laboratories Ltd. is ―. Valiant Laboratories Ltd.’s PEG ratio is 0.00.
PE Ratio―
PS Ratio1.39
PB Ratio1.06
Price to Fair Value1.06
Price to FCF-6.98
Price to Operating Cash Flow-72.94
PEG Ratio0.00
Income Statement
In the last 12 months, Valiant Laboratories Ltd. had revenue of 2.37B and earned -32.68M in profits. Earnings per share was -0.51.
Revenue2.37B
Gross Profit272.66M
Operating Income3.50M
Pretax Income7.68M
Net Income-32.68M
EBITDA63.90M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was -57.24M and capital expenditures -1.33B, giving a free cash flow of -1.39B billion.
Operating Cash Flow-57.24M
Free Cash Flow-1.39B
Free Cash Flow per Share-25.52
Dividends & Yields
Valiant Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change-22.20%
50-Day Moving Average65.94
200-Day Moving Average73.23
Relative Strength Index (RSI)53.39
Average Volume (3m)1.58K
Important Dates
Valiant Laboratories Ltd. upcoming earnings date is Aug 17, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
Valiant Laboratories Ltd. as a current ratio of 1.91, with Debt / Equity ratio of 14.86%
Current Ratio1.91
Quick Ratio1.53
Debt to Market Cap0.14
Net Debt to EBITDA6.13
Interest Coverage Ratio0.18
Taxes
In the past 12 months, Valiant Laboratories Ltd. has paid 40.36M in taxes.
Income Tax40.36M
Effective Tax Rate5.25
Enterprise Valuation
Valiant Laboratories Ltd. EV to EBITDA ratio is 57.65, with an EV/FCF ratio of -7.81.
EV to Sales1.55
EV to EBITDA57.65
EV to Free Cash Flow-7.81
EV to Operating Cash Flow-28.34
Balance Sheet
Valiant Laboratories Ltd. has ₹629.06M in cash and marketable securities with ₹537.68M in debt, giving a net cash position of ₹91.37M billion.
Cash & Marketable Securities₹629.06M
Total Debt₹537.68M
Net Cash₹91.37M
Net Cash Per Share₹1.68
Tangible Book Value Per Share₹48.52
Margins
Gross margin is 12.98%, with operating margin of 0.15%, and net profit margin of -1.38%.
Gross Margin12.98%
Operating Margin0.15%
Pretax Margin0.32%
Net Profit Margin-1.38%
EBITDA Margin2.69%
EBIT Margin0.15%
Analyst Forecast
The average price target for Valiant Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast78.04%
EPS Growth Forecast-16.99%